株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

スマートピル:アプリケーションと世界市場

Smart Pills: Applications and Global Markets

発行 BCC Research 商品コード 502702
出版日 ページ情報 英文 123 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.79円で換算しております。
Back to Top
スマートピル:アプリケーションと世界市場 Smart Pills: Applications and Global Markets
出版日: 2017年05月15日 ページ情報: 英文 123 Pages
概要

世界におけるスマートピルの市場規模は、2015年に7億2,000万米ドルへ達しました。同市場は2016年から2021年にかけて21.1%の年間複合成長率 (CAGR) で成長し、2016年の8億5,000万米ドルから2021年に22億米ドルへ達すると予測されています。

当レポートでは、世界のスマートピル市場について調査分析し、スマートピル・技術の世界市場の概要、実績データ・CAGR予測を含む世界市場の動向分析、市場成長の促進因子・抑制因子・市場シェアを含むスマートピルシステム・技術市場の評価、規制構造ならびに市場・長期的展望に影響を及ぼす主な発展動向に関する情報、セグメント別の分析、産業活動の評価、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 標的疾患・障害

  • 胃腸/消化器疾患
  • 一般的な胃腸疾患・障害
  • 消化系癌
  • 小腸腫瘍/小腸障害
  • その他の慢性疾患

第4章 消化管カプセル内視鏡

  • 歴史的な概要
  • カプセル内視鏡の種類
  • 主な市販・パイプライン製品
  • 将来の発展

第5章 患者モニタリング向けスマートピル

  • 標的疾患
  • 患者モニタリング向けスマートピルの種類・用途
  • 主な市販・パイプライン製品
  • 将来の発展

第6章 ドラッグデリバリー向けスマートピル

  • 経口ドラッグデリバリー向けスマートピル
  • ドラッグデリバリースマートピルの市場ニーズ
  • 標的胃腸疾患・症状
  • ドラッグデリバリースマートピルの特徴
  • 薬剤放出メカニズムの種類
  • 市販・パイプライン製品
  • 将来の発展

第7章 市場規模・成長分析

  • 市場規模・成長分析:地域別
  • 市場規模・成長分析:用途別
  • 市場成長の促進因子・抑制因子

第8章 スマートピル市場における競合情勢

  • スマートピル市場における競合情勢

第9章 市場戦略

  • スマートピル市場におけるM&A
  • 近年のM&A
  • 将来の戦略情勢

第10章 規制構造

  • 規制の背景
  • 薬剤/デバイスコンビネーション製品の規制システム
  • 医療機器・薬剤の規制システム
  • スマートピル向け規制システム

第11章 価格・医療費償還

  • 米国
  • 欧州
  • 日本

第12章 結論:スマートピル・技術の展望

第13章 企業プロファイル

付録A:頭字語

付録B:専門機関

目次
Product Code: PHM181A

Report Highlights

The global market for smart pills reached $720 million in 2015. This market is expected to increase from $850 million in 2016 to $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 21.1% for 2016-2021.

Report Includes:

  • An overview of global market for smart pills and technologies.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Assessment of smart pills systems and technology markets, including market growth drivers, restraints and shares.
  • Information on the regulatory structure, major developments influencing the market and the long-term outlook.
  • Analyses of segments within the overall market including capsule endoscopy systems, gastrointestinal monitoring system, diagnosis and monitoring.
  • Evaluation of industry activity, including licensing agreements, partnerships, and merger and acquisitions.
  • Profiles of major players in the industry.

Report Scope

Smart pills include smart ingestible pill-size devices and technologies (e.g., capsule endoscopy, pill-size drug/device combination-based ingestible electronic tablets, microsize capsules for patient monitoring, etc.), which are relatively new and more advanced and give better outcomes in the diagnosis, drug delivery, treatment adherence, health monitoring, and management associated with various diseases. This report is an analytical business tool whose primary purpose is to describe the thorough evaluation of the global market for smart pills. The format of the study is organized around the following:

  • Detailed description of smart pills and technologies.
  • Demographics and cost burden of targeted diseases.
  • Regulatory structure.
  • Market characterization, unmet need, market size, and segmentation.
  • Market drivers and restraints.
  • Detailed market projections through 2021.
  • Competition and market shares.
  • Pricing and reimbursement.
  • Description of marketed and pipeline (R&D) products along with information about their regulatory status and clinical trials.
  • Observations and conclusions regarding the future of ingestible smart pills.
  • Profiles of market participants and associations.

Analyst Credentials

Dr. Ritu Thakur is an independent consultant based in New Delhi, India with 10+ years of experience in consulting, business/market research, business & report writing, analytics, content development & management and translation. She has prior work experience with Panasonic (Healthcare Division), GlobalData (U.K.-based market research firm) and several other development stage/early stage companies including Biovo, Diabesity, Medibrane, ScaleThings, EndoGI, Ramot Biomedical Eng and NeverWet. In her previous assignments, she has delivered hundreds of small to large scale custom projects on pharmaceutical, medical and biotechnology subjects. She has developed reports for BCC Research for more than four years and has worked as an author for healthcare and other related industries such as pharmaceuticals, biotechnology and medical devices.

Table of Contents

Chapter 1 - Introduction

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing This Study
    • Scope of Report
    • Information Sources
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports

Chapter 2 - Summary and Highlights

  • Summary and Highlights

Chapter 3 - Target Diseases and Disorders

  • Target Diseases and Disorders
    • Gastrointestinal/Digestive Diseases
      • Epidemiology and Economic Burden
      • Mortality
    • Common Gastrointestinal Diseases and Disorders
      • Inflammatory Bowel Disease (IBD)
      • Ulcer Disease
      • Esophagitis/Esophageal Diseases
      • Gastroesophageal Reflux Disease (GERD)
      • Obscure Gastrointestinal Bleeding
      • Celiac Disease
    • Digestive System Cancer
      • Colorectal Cancer
    • Small-bowel Tumors/Small-bowel Diseases
      • Disease Overview
    • Other Chronic Disorders
      • Obesity
      • Diabetes
      • Stroke
      • Hypertension

Chapter 4 - Gastrointestinal Capsule Endoscopy

  • Gastrointestinal Capsule Endoscopy
    • Capsule Endoscopy
  • Historic Overview
    • Capsule Endoscopy
    • Capsule Endoscope Components
    • Target Indications
    • Contraindications
    • Limitations and Risks
  • Types of Capsule Endoscopy
    • Small-bowel Video Capsule Endoscopy
    • Esophageal Video Capsule Endoscopy
    • Colon Capsule Endoscopy
  • Key Marketed and Pipeline Products
    • Marketed Products
    • R&D Pipeline Products
    • Future Developments

Chapter 5 - Smart Pills for Patient Monitoring

  • Smart Pills for Patient Monitoring
    • Target Indications
      • Gastroparesis
      • Other Gastrointestinal Motility Disorders
      • Chronic Constipation
      • Intestinal Dysmotility
    • Types and Applications of Smart Pills for Patient Monitoring
      • Monitoring Smart Pills (pH, Temperature, Pressure)
      • Drug-adherence Smart Pills
    • Key Marketed and Pipeline Products
      • SmartPill Motility Testing System (Medtronic)
      • Proteus Patch Including Ingestible Sensor (Proteus Digital Health)
      • OMOM pH Capsule Monitoring System (Chongqing Jinshan Science & Technology)
      • ABILIFY Smart Pill (ABILIFY Pill + Proteus Ingestible Sensor) (Proteus Digital Health and Otsuka
      • Pharmaceuticals)
      • Smart Pill (Novartis Drugs + Proteus Ingestible Sensor) (Proteus Digital Health and Novartis)
    • Future Developments

Chapter 6 - Smart Pills for Drug Delivery

  • Smart Pills for Drug Delivery
    • Smart Pills for Oral Drug Delivery
    • Market Need for Drug-delivery Smart Pills
    • Target Gastrointestinal Diseases and Indications
      • Inflammatory Bowel Syndrome or Crohn's Disease
      • Ulcerative Colitis
      • Gastroesophageal Reflux Disease
      • Stomach Disease
      • Chronic Gastrointestinal Disorders
      • Diverticular Disease
      • Bowel Tumors
    • Characteristics of Drug-delivery Smart Pills
    • Types of Drug-release Mechanisms
      • Passive Release Mechanisms
      • Active Release Mechanisms
      • Capsule Navigation
      • Passive Locomotion
      • Active Locomotion
    • Marketed and R&D Pipeline Products
      • IntelliCap (Medimetrics, Supported by Philips Research)
      • Novartis Robotic Pill (Novartis and Rani Therapeutics)
      • Novartis Smart Pill (Novartis and Proteus Digital)
      • Hydrophilic Sandwich (HS) (Bio-Images Research)
    • Future Developments

Chapter 7 - Market Size and Growth Analysis

  • Market Size and Growth Analysis
    • Market Size and Growth Analysis by Region
    • Market Size and Growth Analysis by Application
    • Market Growth Drivers and Restraints
      • Gastrointestinal Capsule Endoscopy
      • Smart Pills for Patient Monitoring
      • Smart Pills for Drug Delivery

Chapter 8 - Competitive Landscape in Smart Pills Market

  • Competitive Landscape in Smart Pills Market

Chapter 9 - Market Strategy

  • Market Strategy
    • Mergers and Acquisitions in Smart Pills Market
    • Recent Mergers and Acquisitions
      • Medtronic Acquired Covidien
      • Covidien Acquired Given Imaging
      • Given Imaging Acquired SmartPill's SmartPill GI Monitoring System
      • Given Imaging Acquired Sierra Scientific
      • Given Imaging Acquired Medtronic's Bravo Ph Monitoring System
    • Future Strategic Landscape

Chapter 10 - Regulatory Structure

  • Regulatory Structure
    • Regulatory Background
    • Regulatory Systems for Drug/Device Combination Products
    • Regulatory Systems for Medical Devices and Drugs
      • Regulatory Systems for Medical Devices by Region
      • U.S. FDA Technical Considerations
      • FDA Policy for Low-risk and General Wellness Devices
      • FDA Recalls and Safety Alerts
      • Regulatory Systems for Drugs by Region
    • Regulatory Systems for Smart Pills
      • Old Drug, New Medical Device
      • Old Drug, Old Medical Device
      • New Drug, Old Medical Device
      • New Drug, New Medical Device

Chapter 11 - Pricing and Reimbursement

  • Pricing and Reimbursement
    • U.S.
      • Medical Devices
      • Pharmaceuticals
    • Europe
      • Medical Devices
      • Pharmaceuticals
    • Japan
      • Medical Devices
      • Pharmaceuticals
      • Other Asia Countries

Chapter 12- Conclusions - Outlook for Smart Pills and Technologies

  • Outlook for Smart Pills and Technologies
    • Major Developments to Influence the Market
      • Technological Developments: Smart Ingestible Pill-size Medical Sensors and Software Applications
      • Social Developments: Social Media and Rise of Smartphone Use
      • Demographic and Economic Trends: Income Growth in Developing Markets
    • Long-term Outlook for Smart Pills

Chapter 13 - Company Profiles

  • Company Profiles

Appendix A Acronyms

  • Acronyms

Appendix B Professional Organizations

  • Professional Organizations
    • American Association for Cancer Research (AACR)
    • American Gastroenterological Association (AGA)
    • American Society for Gastrointestinal Endoscopy (ASGE)
    • Center for Drug Evaluation and Research (CDER)
    • Center for Devices and Radiological Health (CDRH)
    • Center for Medicare and Medicaid Services (CMS)
    • European Databank for Medical Devices (EUDAMED)
    • Food and Drug Administration (FDA or USFDA)
    • Global Cancer Foundation
    • Hormone Foundation
    • International Diabetes Federation (IDF)
    • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
    • National Center for Biotechnology Information (NCBI)
    • National Institute of Aging (NIA)
    • Pharmaceuticals and Medical Devices Agency (PMDA)
    • World Cancer Research Fund International
    • World Gastroenterology Organisation (WGO)
    • World Health Organization (WHO)

Lists of Tables and Figures

About BCC Research

  • About BCC Research
  • BCC Library Access
  • BCC Custom Research

List of Tables

  • TABLE 1: Summary Table: Global Market for Smart Pills, by Region, through 2021 ($ Millions)
  • TABLE 2: Mortality from Digestive Diseases, by Region, through 2021 (Thousands)
  • TABLE 3: Epidemiology of Colon Cancer, by Region, Through 2030 (Thousands)
  • TABLE 4: Global Deaths, by Various Cancer Types, through 2030 (Thousands)
  • TABLE 5: Distribution of Global Deaths, by Various Cancer Types, 2015 (% of Total Deaths Due to Cancer)
  • TABLE 6: BMI Calculation
  • TABLE 7: BMI Categories Based on Increasing Health Risks
  • TABLE 8: Trends in Obesity Composition of the World's Population, through 2020 (Millions)
  • TABLE 9: U.S. Obesity and Severe Obesity vs. General Population, through 2020 (Millions)
  • TABLE 10: Global Diabetes Types (% of Total Diabetes)
  • TABLE 11: Global Prevalence of Diabetes, by Type, through 2040 (Millions)
  • TABLE 12: Global Incidence of Congestive Heart Failure and Stroke, through 2030 (Thousands)
  • TABLE 13: Hypertension Epidemiology, by Patient Group, 2015 (% of Total Patients)
  • TABLE 14: Diagnostic Smart Pills, Key Marketed Products
  • TABLE 15: Key FDA Approvals Covering Gastrointestinal Capsule Endoscopy
  • TABLE 16: Key R&D Diagnostic Smart Pill Products
  • TABLE 17: Smart Pills for Patient Monitoring
  • TABLE 18: Smart Capsule Solutions for Drug Delivery
  • TABLE 19: Smart Pills for Oral Drug Delivery
  • TABLE 20: Global Market for Smart Pills, by Region, through 2021 ($ Millions)
  • TABLE 21: Global Market for Smart Pills, by Application, through 2021 ($ Millions)
  • TABLE 22: Global Market for Smart Pills, by Leading Companies, 2016 ($ Millions/%)
  • TABLE 23: Recent Key Strategic Deals in Smart Pills Market
  • TABLE 24: Differences in Regulatory Approval in the U.S. and Europe
  • TABLE 25: Trends in Per Capita Real GDP Growth, by Region, 2012-2015 (Annual Average Percentage Change)
  • TABLE 26: List of Acronyms

List of Figures

  • FIGURE 1: Summary Figure: Global Market for Smart Pills, by Region, 2015-2021 ($ Millions)
  • FIGURE 2: Mortality from Digestive Diseases, by Region, 2015-2021 (Thousands)
  • FIGURE 3: Epidemiology of Colon Cancer, by Region, 2000-2030 (Thousands)
  • FIGURE 4: Global Deaths, by Various Cancer Types, 2000-2030 (Thousands)
  • FIGURE 5: Distribution of Global Deaths, by Various Cancer Types, 2015 (% of Total Deaths Due to Cancer)
  • FIGURE 6: Trends in Obesity Composition of the World's Population, 2012-2020 (Millions)
  • FIGURE 7: U.S. Obesity and Severe Obesity vs. General Population, 2015-2021 (Millions)
  • FIGURE 8: Global Diabetes Types (% of Total Diabetes)
  • FIGURE 9: Global Prevalence of Diabetes, by Type, 2015-2040 (Millions)
  • FIGURE 10: Global Incidence of Congestive Heart Failure and Stroke, 2004-2030
  • FIGURE 11: Hypertension Epidemiology, by Patient Group, 2015 (% of Total Patients)
  • FIGURE 12: Global Market for Smart Pills, by Region, 2015-2021 ($ Millions)
  • FIGURE 13: Global Market for Smart Pills, by Application, 2015-2021 ($ Millions)
  • FIGURE 14: Global Market for Smart Pills, by Leading Companies, 2016 (%)
  • FIGURE 15: Trends in Per Capita Real GDP Growth, by Region, 2012-2015 (Annual Average Percentage Change)
Back to Top